Download the ICS Branding Pack
Open Discussion ePoster Session 21 Open Discussion ePosters 418 Improvement of symptomatology and satisfaction in patients with neurogenic and no neurogenic lower urinary tract dysfunction, treated with sacral neuromodulation.
Plenary Podium Session 1 Insights into Neural Pathways 6 Quality of Life Mathematical modeling comparing Sacral Neuromodulation vs. Botox A in the treatment of Overactive Bladder Syndrome in Colombia
Dr Juan Carlos Castaño declared on the Wednesday 29th April 2020 that they had the following existing or known future financial relationships or affiliations:
ICS Neurourology Promotion Committee
Developing World & IC Working Group
Guidelines of Pelvic Neuromodulation Subcommittee
Sacral Neuromodulation (SNM) Working Group